- RecruitingPHASE1
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
This study is looking into a new treatment called KRC-01 for cervical cancer. It aims to see if KRC-01 is safe, if patients can tolerate it, and if it helps shrink tumours when used with standard treatments like radiotherapy and chemotherapy.
For: Cervical CancerIndia · Thailand · United Kingdom - AuthorisedTherapeutic exploratory (Phase II)
Phase II Clinical Trial of KORTUC (KRC-01) Combined with Radiotherapy for Locally Advanced Rectal Cancer: Towards a New Organ Preservation Approach (K-BOOST)
This study is testing a new drug, KRC-01, with standard radiotherapy for locally advanced rectal cancer. The main goal is to see if this combination can help shrink tumors completely, potentially avoiding major surgery. It's an early-stage study for people with specific types of rectal cancer.
For: Locally advanced high‑risk stage III rectal adenocarcinoma (non‑metastatic)France